xCures Inc Press Releases - EIN Presswire - Press Release Distribution Service

Published on October 24, 2022 - 17:39 GMT

xCures and mProbe partner to help cancer patients determine optimal treatments

xCures partners with mProbe, to leverage their targeted proteomics platform for profiling individual patients' cancer tissues for actionable drug targets OAKLAND, CALIFORNIA, UNITED STATES, October 24, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc. is …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on August 25, 2022 - 14:05 GMT

xCures and Oblato announce the launch of a Compassionate Use program for OKN-007

Oblato’s first-in-class small molecular OKN-007 will be available through a newly opened compassionate use protocol. OAKLAND, CALIFORNIA, UNITED STATES, August 25, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc., a clinical study platform provider, and Oblato, …

Distribution channels: Business & Economy, Companies ...

Published on August 24, 2022 - 14:05 GMT

Pancreatic Cancer Patients Will Now Have Remote Access to Precision Nutrition Trial Through New Partnership

xCures and Vault Health integration creates a decentralized platform to benefit pancreatic cancer research and facilitate enrollment in Faeth’s NEAAR-001 study OAKLAND, CALIFORNIA, UNITED STATES, August 24, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc. is …

Distribution channels: Business & Economy, Companies ...

Published on July 19, 2022 - 14:15 GMT

xCures partners with Travera to support advanced carcinoma patients and their physicians

Decentralized clinical trial for patients with advanced carcinomas helps determine their cancer’s response to specific drugs OAKLAND, CALIFORNIA, UNITED STATES, July 19, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc. is proud to announce their partnership with …

Distribution channels: Business & Economy, Companies ...

Published on June 21, 2022 - 14:15 GMT

xCures and Novocure® partner to better understand quality of life in glioblastoma

Innovative collaboration focused on developing the first comprehensive Quality of Life dataset for glioblastoma patients OAKLAND, CALIFORNIA, UNITED STATES, June 21, 2022 /⁨EINPresswire.com⁩/ -- ] xCures, Inc., is proud to announce their partnership with …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on June 3, 2022 - 16:45 GMT

Prognos Health and xCures Partner to enable Access to Real World Oncology Datasets

The new collaboration focuses on improving outcomes by continuous learning from every patient’s journey across diverse datasets CHICAGO, IL, UNITED STATES, June 3, 2022 /⁨EINPresswire.com⁩/ -- Today, at the annual meeting of the American Society of …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on June 2, 2022 - 18:00 GMT

xCures joins C-Path's Cure Drug Repurposing Collaboratory to Deliver AI-enabled Data Abstraction of Health Records

Members of CDRC will be able to utilize xCures’ technology to quickly abstract and structure clinical data to support drug repurposing studies in rare cancer. OAKLAND, CALIFORNIA, UNITED STATES, June 2, 2022 /⁨EINPresswire.com⁩/ -- xCures today announced …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on March 10, 2022 - 21:00 GMT

xCures announces real world biomarker study for patients with FGFR-mutant bladder cancer receiving Balversa®

Tyra Biosciences supported study investigates if non-invasive blood and urine samples provide biomarkers to assess clinical response to erdafitinib treatment OAKLAND, CALIFORNIA, UNITED STATES, March 10, 2022 /⁨EINPresswire.com⁩/ -- Today, xCures …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on March 3, 2022 - 14:00 GMT

xCures and BioSpark partner to boost Real World Oncology Data offerings

New partnership allows for a 40,000+ patient dataset to unlock new insights into cancer treatments and outcomes. OAKLAND, CA, UNITED STATES, March 3, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc. and BioSpark, Inc. are proud to announce their strategic …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 17, 2022 - 14:00 GMT

TARGET: Cancer podcast to be hosted by media personality Dr. Sanjay Juneja - TheOncDoc

Oncologist and cancer educator Dr. Sanjay Juneja will host xCures’ informative podcast on cancer and technology OAKLAND, CA, UNITED STATES, February 17, 2022 /⁨EINPresswire.com⁩/ -- xCures, a direct-to-patient, and direct-to-physician oncology platform, …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...

Published on November 12, 2021 - 17:12 GMT

xCures presents the results of their oncology platform at the 2021 SNO Annual Meeting

xCures’ poster at the SNO meeting will show results from their XCELSIOR platform of real-world datasets and clinical outcomes in CNS cancer patients. OAKLAND, CALIFORNIA, UNITED STATES, November 12, 2021 /⁨EINPresswire.com⁩/ -- Today, xCures announced …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on November 8, 2021 - 18:00 GMT

xCures launches xDECIDE to help oncologists find better treatment options for their patients

Portal helps oncologists find the most recent and relevant therapeutic options so they can focus on treatment evaluation OAKLAND, CALIFORNIA, UNITED STATES, November 8, 2021 /⁨EINPresswire.com⁩/ -- xCures announced today the release of xDECIDE, the latest …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on May 19, 2021 - 13:45 GMT

xCures partners with FibroFighters to launch a real-time learning platform for Fibrolamellar Hepatocellular Carcinoma

Collection and analysis of real-time data about Fibrolamellar aim to deliver essential information for doctors and patients about this rare form of liver cancer OAKLAND, CALIFORNIA, UNITED STATES, May 19, 2021 /⁨EINPresswire.com⁩/ -- Today, xCures …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on May 18, 2021 - 14:15 GMT

xCures partners with CureScience to make leading translational research available to advanced cancer patients

Doctors and patients will benefit from the integration of xCures’ patient-oriented tracking infrastructure and CureScience's precision medicine tools OAKLAND, CALIFORNIA, UNITED STATES, May 18, 2021 /⁨EINPresswire.com⁩/ -- Today, xCures announced its …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on April 27, 2021 - 13:15 GMT

xCures launches xACCESS for Providers

A.I.-assisted portal makes it easier for healthcare providers to enroll cancer patients in managed access programs OAKLAND, CALIFORNIA, UNITED STATES, April 27, 2021 /⁨EINPresswire.com⁩/ -- Today, xCures Inc. launched xACCESS for Providers – a portal for …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on January 12, 2021 - 18:15 GMT

xCures announces collaboration with CancerCompass to better support patients and caregivers through their cancer journey

SAN FRANCISCO, CALIFORNIA, UNITED STATES, January 12, 2021 /⁨EINPresswire.com⁩/ -- Today, xCures announced their collaboration with CancerCompass, allowing consumers who contact CancerCompass to access the xCures' platform and services. " …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on October 10, 2019 - 13:45 GMT

Oncology Pioneer xCures Names Experts to Advisory Boards

Prominence of Scientific and company Advisory Board signals attraction to xCures’ novel patient-centric approach to treatment and continuous learning for cancer LOS ALTOS, CA, USA, October 10, 2019 /⁨EINPresswire.com⁩/ -- Today, xCures Inc. announced the …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...